Archive | Oncology RSS feed for this section

Less is more

“By making treatments more tolerable and accessible to a broader range of cancer patients, mCT is an example that less can sometimes be more.” (more…)

Read full story · Comments { 0 }

Clinical and ethical considerations for terminal cancer patients

When decisions arise concerning the treatment of dying patients, these options present complex clinical and ethical dilemmas. Many are faced with decisions about the best treatment to ease a patient’s final suffering, or perhaps even a decision will need to be made about terminating treatment altogether. (more…)

Read full story · Comments { 0 }

Cancer: Palliative care programme

This ‘advanced stage’ of cancer brings anxiety and uncertainty and is often not easy to accept, for both patients and their loved ones. (more…)

Read full story · Comments { 0 }

New era in breast cancer treatment

Metronomic chemotherapy (MCT) is a reasonable treatment option for patients who do not require rapid tumour response. (more…)

Read full story · Comments { 0 }

Does vitamin D enhance the survival rate of breast cancer patients?

There have been several studies into the link between breast cancer survival and the ‘sunshine vitamin’ (vitamin D).  (more…)

Read full story · Comments { 1 }

Does vitamin D enhance the survival rate of breast cancer patients?

There have been several studies into the link between breast cancer survival and the ‘sunshine vitamin’ (vitamin D).  (more…)

Read full story · Comments { 0 }

The accuracy of p16/Ki-67 and HPV test in the detection of CIN2/3 in women diagnosed with ASC-US or LSIL

Cervical cancer has the greatest potential for prevention as it develops over time. However, it remains an important public health problem, especially in developing countries where it is associated with high incidence rates and mortality. Cervical cancer is the second most common cancer for woman worldwide and the fourth most common cause of death from […]

Read full story · Comments { 0 }

Brachytherapy facility an important development in Africa’s fight against cancer

A newly launched brachytherapy facility with advanced technology at a Johannesburg hospital provides patients from around Africa with significantly more options for the treatment of various kinds of cancers, and is ‘an important new tool in the fight against the disease’. (more…)

Read full story · Comments { 0 }

Assessment of HER2 status in breast cancer

Breast cancer continues to rank second, after lung cancer, as a cause of cancer death in women. It is also a leading cause of premature mortality in women. Breast cancer is the most common cancer in women worldwide. In 2012, deaths from breast cancer accounted for 783 000 years of potential life lost and an average […]

Read full story · Comments { 0 }

Invading the body’s immune response

Melanoma is known as the most immunogenic of all solid tumours. The reason for this is the disease’s ability to invade the body’s immune response, according to Dr Daniel Vorobiof of the Sandton Oncology Centre. He was one of the keynote speakers at the inaugural Skin Cancer Foundation Update held recently in Johannesburg. In 2008 […]

Read full story · Comments { 0 }

Exploring new frontiers

Prostate cancer is the most common cancer among men, with approximately 237 800 new cases and 85 200 deaths annually in Europe. About 10% – 20% of men with prostate cancer initially present with metastatic disease. (more…)

Read full story · Comments { 1 }

Knowledge is power

Breast Cancer is the most common female cancer in the world, and is often spoken about at length. But how many women actually fully understand the jargon and terminology thrown around when it comes to understanding breast cancer? (more…)

Read full story · Comments { 0 }